Spiritual well-being, distress and quality of life in Hispanic women diagnosed with cancer undergoing treatment with chemotherapy.


Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
11 2022
Historique:
revised: 21 06 2022
received: 11 04 2022
accepted: 12 07 2022
pubmed: 20 9 2022
medline: 10 11 2022
entrez: 19 9 2022
Statut: ppublish

Résumé

Previous studies have examined whether spiritual well-being is associated with cancer outcomes, but minority populations are under-represented. This study examines associations of baseline spiritual well-being and change in spiritual well-being with change in distress and quality of life, and explores potential factors associated with changes in spiritual well-being among Hispanic women undergoing chemotherapy. Participants completed measures examining spiritual well-being, distress, and quality of life prior to beginning chemotherapy and at weeks 7 and 13. Participants' acculturation and sociodemographic data were collected prior to treatment. Mixed models were used to examine the association of baseline spiritual well-being and change in spiritual well-being during treatment with change in distress and quality of life, and to explore whether sociodemographic factors, acculturation and clinical variables were associated with change in spiritual well-being. A total of 242 participants provided data. Greater baseline spiritual well-being was associated with less concurrent distress and better quality of life (p < 0.001), as well as with greater emotional and functional well-being over time (p values < 0.01). Increases in spiritual well-being were associated with improved social well-being during treatment, whereas decreases in spiritual well-being were associated with worsened social well-being (p < 0.01). Married participants reported greater spiritual well-being at baseline relative to non-married participants (p < 0.001). Greater spiritual well-being is associated with less concurrent distress and better quality of life, as well as with greater emotional, functional, and social well-being over time among Hispanic women undergoing chemotherapy. Future work could include developing culturally targeted spiritual interventions to improve survivors' well-being.

Identifiants

pubmed: 36121699
doi: 10.1002/pon.6038
pmc: PMC10115137
mid: NIHMS1890718
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1933-1940

Subventions

Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA196953
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA240139
Pays : United States
Organisme : NCI NIH HHS
ID : UG3 CA260317
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA255875
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA206456
Pays : United States

Informations de copyright

© 2022 John Wiley & Sons Ltd.

Références

J Clin Oncol. 2007 Feb 10;25(5):555-60
pubmed: 17290065
J Psychosoc Oncol. 2006;24(3):19-52
pubmed: 17088240
J Relig Health. 2021 Jun;60(3):1895-1907
pubmed: 33439398
Cancer. 2015 Mar 15;121(6):916-26
pubmed: 25411008
Oncol Nurs Forum. 2005 Mar 05;32(2):250-6
pubmed: 15759063
Gen Hosp Psychiatry. 2003 Jul-Aug;25(4):277-83
pubmed: 12850660
Cancer. 2015 Nov 1;121(21):3779-88
pubmed: 26258730
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Psychooncology. 2018 Feb;27(2):477-483
pubmed: 28637083
Psychooncology. 2018 Apr;27(4):1305-1311
pubmed: 29462503
Cancer. 2015 Nov 1;121(21):3760-8
pubmed: 26258868
CA Cancer J Clin. 2021 Nov;71(6):466-487
pubmed: 34545941
Ann Behav Med. 2002 Winter;24(1):49-58
pubmed: 12008794
J Cancer Surviv. 2011 Jun;5(2):191-207
pubmed: 21274649
Psychooncology. 1999 Sep-Oct;8(5):439-50
pubmed: 10559803
Health Psychol. 2009 Mar;28(2):147-56
pubmed: 19290706
Cancer. 2014 Sep 15;120(18):2902-9
pubmed: 24853866
Psychooncology. 2018 Jan;27(1):333-338
pubmed: 28557067
Sci J Edu. 2020;8(4):100-107
pubmed: 34532506
Psychooncology. 2001 Jan-Feb;10(1):88-92
pubmed: 11180580
Cancer. 2015 Nov 1;121(21):3769-78
pubmed: 26258536
J Cancer Surviv. 2015 Sep;9(3):441-9
pubmed: 25576214
Psychooncology. 2020 Apr;29(4):711-718
pubmed: 31876012
Psychooncology. 2010 Mar;19(3):264-72
pubmed: 19367561
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
Am Surg. 2018 Nov 1;84(11):1787-1789
pubmed: 30747634
J Palliat Med. 2020 Apr;23(4):489-497
pubmed: 31663811
Cancer. 2018 Aug 1;124(15):3231-3239
pubmed: 29757459
J Psychosoc Oncol. 2017 Jul-Aug;35(4):424-437
pubmed: 28332946
Cancer. 2008 Sep 1;113(5):1058-67
pubmed: 18618494
Med Care. 2003 May;41(5):582-92
pubmed: 12719681
Psychooncology. 2009 Aug;18(8):831-40
pubmed: 19034922
J Relig Health. 2015 Dec;54(6):2367-75
pubmed: 25711211
Eval Health Prof. 2005 Jun;28(2):172-91
pubmed: 15851772
Am J Psychother. 2021 Mar 01;74(1):13-21
pubmed: 33028079
J Altern Complement Med. 2008 Oct;14(8):931-8
pubmed: 18925865

Auteurs

Anna Barata (A)

Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.

Aasha I Hoogland (AI)

Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.

Brent J Small (BJ)

School of Aging Studies, University of South Florida, Tampa, Florida, USA.

Karina I Acevedo (KI)

Ponce Health Sciences University, Ponce, Puerto Rico, USA.

Michael H Antoni (MH)

Department of Psychology, Sylvester Comprehensive Cancer Center, University of Miami, and Cancer Control Program, Miami, Florida, USA.

Brian D Gonzalez (BD)

Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.

Paul B Jacobsen (PB)

Healthcare Delivery Research Program, National Cancer Institute, Bethesda, Maryland, USA.

Suzanne C Lechner (SC)

Department of Psychology, Sylvester Comprehensive Cancer Center, University of Miami, and Cancer Control Program, Miami, Florida, USA.

Dinorah Martinez Tyson (DM)

College of Public Health, University of South Florida, Tampa, Florida, USA.

Cathy D Meade (CD)

Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.

Yvelise Rodriguez (Y)

Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.

John M Salsman (JM)

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA.

Allen C Sherman (AC)

Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

Steven K Sutton (SK)

Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, USA.

Heather S L Jim (HSL)

Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH